Brain aging expert challenges the existence of Alzheimer's as a 'disease'

January 10, 2008

Case Western Reserve University School of Medicine professor of neurology, Peter Whitehouse, M.D., Ph.D., challenges conventional wisdom and assumptions of brain aging in his new book, “The Myth of Alzheimer’s: What You Aren’t Being Told About Today’s Most Dreaded Disease.”

In his provocative and ground-breaking new book, Dr. Whitehouse questions current approaches to Alzheimer’s disease (AD) diagnosis and treatment and brings a new understanding to everything we thought we knew about brain aging. Dr. Whitehouse and co-author Daniel George, M. Sc., published “The Myth of Alzheimer’s” to expose what they believe to be the unsound clinical, political, and scientific framework of AD and explain why it continues to be so difficult to address a condition concerning so many people as they age.

According to the founder of the University Memory and Aging Center at Case Western Reserve University and University Hospitals Case Medical Center, “AD cannot be biologically or clinically differentiated from normal aging. There is no one profile of AD that is consistent from person to person,” says Dr. Whitehouse. “Alzheimer’s is a heterogeneous process because it reflects the different way people’s brains age over their lifetimes.” The book claims AD represents our culture’s attempt to make sense of a natural process of brain aging that we cannot control; all the biological hallmarks of AD are also the hallmarks of normal, albeit severe, forms of brain aging. “The promise of a panacea for one of our most dreaded ‘diseases’ is a powerful cultural myth,” says Whitehouse, “and one purveyed by powerful pharmaceutical companies, advocacy organizations, and private researchers with much profit to gain.” The book points out that most scientists in the field of AD research believe a cure is unlikely and we need to invest our dollars more wisely by putting them toward prevention and care rather than predominantly in a cure.

Based on twenty-five years as a clinician and educator caring for persons with aging associated cognitive challenges and on his experience as the co-founder (with his wife Catherine) of an internationally recognized and nationally awarding wining intergenerational school affiliated with Case Western Reserve, Dr. Whitehouse shares his experiences and accumulated wisdom about ageing well.

The term “Alzheimer’s disease” generates fear, paranoia, angst, and stigmatization while evoking powerful social and emotional images. For the millions of people diagnosed with AD and their families, this book will help them understand why what they have been told may be incomplete, even wrong; why the treatment they are probably being given is inadequate; and most importantly, how they can get the help they need. “The Myth of Alzheimer’s” encourages readers to think about brain aging not as a disease, but as a lifelong process fraught with challenges which will change society’s whole approach to aging and add quality to our later years and to the lives of those we love.

With a caring, yet scientifically grounded, message of prevention, Whitehouse and George explore measures to enhance the likelihood of successful cognitive aging, and presents examples of how to maintain cognitive vitality and a sense of fulfillment and social contribution as we age. Deemed a “landmark book” by Harry Moody of the AARP, “The Myth of Alzheimer’s” provides answers for when to see a doctor for memory loss, how to find the right medical team, and how to develop a collaborative relationship with your physician.

Backed up by extensive research, full of practical advice and information, and infused with hope, Dr. Whitehouse and Mr. George’s book strives to liberate people from the crippling label of AD and teach them how to best approach memory loss and learn how to age with wisdom, while preserving their quality of life.

“The Myth of Alzheimer’s” answers important questions such as:

-- Is Alzheimer’s actually a disease?
-- What is the difference between a naturally aging brain and an Alzheimer’s brain?
-- How effective are the current drugs for AD" Are they worth the money we spend on them?
-- What kind of hope does science really have for the treatment of memory loss" Are there alternative interventions that can keep our aging bodies and minds sharp?
-- What promise does genetic research actually hold?
-- What would a world without Alzheimer’s look like and how do we as individuals and as human communities get there?

Source: Case Western Reserve University

Explore further: 50 years of diabetes research and treatment

Related Stories

50 years of diabetes research and treatment

June 7, 2015
From how people test their glucose levels to how long they can expect to live, almost everything has changed over the past 50 years for Americans with diabetes. A special symposium held at the American Diabetes Association's ...

Prenatal testosterone linked to increased risk of language delay for male infants, study shows

January 26, 2012
New research by Australian scientists reveals that males who are exposed to high levels of testosterone before birth are twice as likely to experience delays in language development compared to females. The research, published ...

Researchers advance autism diagnosis

June 5, 2014
(Medical Xpress)—University of Queensland researchers have led a study that will help unravel the genetic mystery of autism and, for the first time, help diagnose children under two years of age with the disorder.

NIH stops clinical trial on combination cholesterol treatment

May 26, 2011
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, ...

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

4 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

googleplex
3 / 5 (2) Jan 10, 2008
Denial sells.
Sadly AD is a disease. If it were simply a part of normal aging then we would see everyone get it. Some people never show the plaques of Amyloid Beta into there century years. I believe that it is part of a new class of disease, a molecular or nano disease.
Disease proof:
If it were not a disease then how come it can be transfered from one individual to another in tests on model species. If it were an aging process then this would not happen.
Rametarin
2.5 / 5 (2) Jan 10, 2008
You raise good points, Google.
NanoStuff
not rated yet Jan 13, 2008
Call it a 'normal' part of aging as you choose, that's just semantics. Bottom line is it's a debilitating condition and needs to be resolved. Being 'normal', whatever that means, does not suggest it's inevitable and should apparently be accepted. If Alzheimer's IS a natural part of aging, then it's obvious what must be done, cure normal aging, a disease in itself. There is no distinction between age-related conditions such as Alzheimer's and aging itself. Aging is defined by such degeneration.

This book will serve nothing other than to unjustly discredit competent AD researchers that are continuously making progress towards better treatment. To suggest they should be stripped of funding because of one man who failed with his career choice and wrote a book about it is despicable. I'm happy to give this my "Most worthless article of the year" award. It may be the beginning of the year, but I doubt this one is going to be outdone.

VOR
not rated yet Jun 25, 2009
There may or may not be some useful info/thoughts in the book. But to title it "The Myth of Alzheimer's" is not a good idea, even if they are only trying to create controversy for attention (which is itself not a credible approach). The biggest problem is the title and attitude doesnt really serve the public, despite some rationals that try to say it does. AD is a 'bad thing' no matter how you try to 'couch' it. Nobody wants it, any everyone would prefer to avoid it. So whatever point they may be trying to make with this angle, its superfluous at best. Demonizing the term AD and saying it creates fear etc is just not a concern of relative significance in the face of the impact of AD itself. AD and dementia are pretty much the same in my book, and even if one causes a little more anxiety to think about, well that difference, if it exists, is a miniscule 'affect of medical vernacular'. It's just like saying we should stop using the word 'cancer'.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.